Petra Herzig

3PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 05, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|May 29, 2026
Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

|Nov 19, 2025
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinoma.

Silvia Guglietta, Anne Bärenwaldt, Anthony Sonrel

Pageof 1

Frequent Collaborators

3 joint publications

Alfred Zippelius

2 joint publications

Lukas Bubendorf

2 joint publications

Frank Stenner

2 joint publications

Heinz Läubli